280 related articles for article (PubMed ID: 6317296)
21. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces.
Hazenberg MP; Pennock-Schröder AM; Van den Boom M; Van de Merwe JP
J Hyg (Lond); 1984 Aug; 93(1):27-34. PubMed ID: 6086749
[TBL] [Abstract][Full Text] [Related]
22. Membrane-disorganizing property of polymyxin B nonapeptide.
Lam C; Hildebrandt J; Schütze E; Wenzel AF
J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of the antibiotic actions of gramicidin Dubos & polymyxin B.
Radhakrishna G; Ramachandran LK
Indian J Biochem Biophys; 1977 Jun; 14(2):138-41. PubMed ID: 73500
[No Abstract] [Full Text] [Related]
24. Flow microcalorimetric assay of antibiotics--IV. Polymyxin B sulphate, neomycin sulphate, zinc bacitracin and their combinations with Escherichia coli suspended in buffer plus glucose medium.
Joslin Kjeldsen N; Beezer AE; Miles RJ; Sodha H
J Pharm Biomed Anal; 1989; 7(7):871-5. PubMed ID: 2490096
[TBL] [Abstract][Full Text] [Related]
25. Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics-polymyxins combinations.
Polyudova T; Lemkina L; Eroshenko D; Esaev A
Arch Microbiol; 2024 Mar; 206(4):191. PubMed ID: 38520490
[TBL] [Abstract][Full Text] [Related]
26. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
Larsen JL; Søgaard H
Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
[No Abstract] [Full Text] [Related]
27. Flow microcalorimetric assay of antibiotics--II. Neomycin sulphate and its combinations with polymyxin B sulphate and zinc bacitracin on interaction with Bacillus pumilus (NCTC 8241).
Joslin Kjeldsen N; Beezer AE; Miles RJ
J Pharm Biomed Anal; 1989; 7(7):859-64. PubMed ID: 2490094
[TBL] [Abstract][Full Text] [Related]
28. Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.
Kassamali Z; Prince RA; Danziger LH; Rotschafer JC; Rhomberg PR; Jones RN
Antimicrob Agents Chemother; 2015 Dec; 59(12):7823-5. PubMed ID: 26392511
[TBL] [Abstract][Full Text] [Related]
29. The utility of polysporin ointment in the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study.
Fung S; O'Grady S; Kennedy C; Dedier H; Campbell I; Conly J
Infect Control Hosp Epidemiol; 2000 Oct; 21(10):653-5. PubMed ID: 11083183
[TBL] [Abstract][Full Text] [Related]
30. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide.
Duwe AK; Rupar CA; Horsman GB; Vas SI
Antimicrob Agents Chemother; 1986 Aug; 30(2):340-1. PubMed ID: 3021053
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300.
Suzuki M; Yamada K; Nagao M; Aoki E; Matsumoto M; Hirayama T; Yamamoto H; Hiramatsu R; Ichiyama S; Iinuma Y
Emerg Infect Dis; 2011 Oct; 17(10):1917-20. PubMed ID: 22000371
[TBL] [Abstract][Full Text] [Related]
32. [Sensitivity of Bacillus pyocyaneus (Pseudomonas aeruginosa) to antiseptics and antibiotics. VIII. Action of the combination zinc bacitracin, neomycin sulfate and polymyxin B sulfate on 155 strains of Pseudomonas aeruginosa (1st part)].
Delmotte A; Beumer J
Therapie; 1975; 30(2):289-98. PubMed ID: 169602
[No Abstract] [Full Text] [Related]
33. The efficacy of Polysporin First Aid Antibiotic Spray (polymyxin B sulfate and bacitracin zinc) against clinical burn wound isolates.
Walton MA; Carino E; Herndon DN; Heggers JP
J Burn Care Rehabil; 1991; 12(2):116-9. PubMed ID: 2050717
[TBL] [Abstract][Full Text] [Related]
34. Polymyxin B-modified conjugated oligomer nanoparticle for targeted identification and enhanced photodynamic antimicrobial therapy.
Jiang Q; Yan X; Jiao D; Zhang J; Wu Y; Cheng Y
Chem Commun (Camb); 2021 Oct; 57(85):11244-11247. PubMed ID: 34633009
[TBL] [Abstract][Full Text] [Related]
35. Enantiotracin.
McDougal PG; Griffin JH
Bioorg Med Chem Lett; 2003 Jul; 13(13):2239-40. PubMed ID: 12798342
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
[TBL] [Abstract][Full Text] [Related]
38. Novel derivatives of polymyxins.
Vaara M
J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone.
Brehm-Stecher BF; Johnson EA
Antimicrob Agents Chemother; 2003 Oct; 47(10):3357-60. PubMed ID: 14506058
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA.
van der Linden DS; Short D; Dittmann A; Yu PL
Biotechnol Lett; 2009 Aug; 31(8):1265-7. PubMed ID: 19396584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
